[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572848":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":10,"responsibleParty":19,"collaborators":10,"id":23,"slug":10,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":10,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":31,"enrollmentInfo":32,"targetDuration":35,"studyType":36,"phases":10,"briefSummary":37,"conditions":38,"keywords":40,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Progestin Primed Ovarian Stimulation Protocol group",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Antagonist Protocol group",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Khaled Mostafa Principal Investigator, M.Sc","CONTACT","01004770872","khaledmostafa8200893@gmail.com",{"type":20,"investigatorFullName":21,"investigatorTitle":22,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Khaled Mostafa Ahmed","Comparison between progestin primed ovarian stimulation protocol and antagonist protocol in hyper-responder patients schaduled for freeze all policy","100572848",false,"NCT06738602","Difference Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol","Comparison Between Progestin Primed Ovarian Stimulation Protocol and Antagonist Protocol in Hyper-responder Patients Schaduled for Freeze All Policy","Inclusion Criteria:\n\n• All hyper responder patients according to Olivera equation for overian response peridiction index\n\nExclusion Criteria:\n\n* All normal and poor responder patients according to Olivera equation for overian response peridiction index.\n* Sever male factor infertility","FEMALE","20 Years","40 Years",{"count":33,"type":34},270,"ESTIMATED","12 Months","OBSERVATIONAL","compare the effectiveness and safety of the progestin primed ovarian stimulation (PPOS) protocol versus the antagonist protocol in hyper-responder patients scheduled for a freeze-all policy",[39],"Infertility Assisted Reproductive Technology",[41],"progestin primed ovarian stimulation","NOT_YET_RECRUITING","2024-12-13",{"date":45,"type":46},"2024-12-17","ACTUAL",{"date":48,"type":34},"2024-12-30",{"date":50,"type":34},"2027-12-30",{"name":5,"class":6}]